chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Very cold; Headache; issues with his lower extremities; he cannot walk; Body does not work anymore; Throwing up; bad feeling; This is a spontaneous report from a contactable consumer (patient). A 75-year-old male patient received the first dose of BNT162B2 (Pfizer-BIONTECH Covid-19 Vaccine; Lot number: LE3301), via an unspecified route of administration in the right arm on 12Jan2021 at 15:30 as a single dose for COVID-19 immunisation. Medical history included belief that he had agent orange and tiredness. The patient did not have additional vaccines administered on the same date as the Pfizer vaccine and did not have vaccinations within four weeks. The patient's concomitant medications were not reported. The patient previously received a flu shot in October (year unspecified). On 12Jan2021, the patient was throwing up. The patient stated that his whole body has gone, it did not work anymore, his legs have gone out, and was having headaches on 13Jan2021. The patient initially stated that the feeling that his body did not work anymore started six hours after he got the vaccine. He later clarified and stated it started on 13Jan2021. He further clarified that what he meant by the body did not work was issues with his lower extremities, he cannot walk and he was having a lot of headaches. The throwing up started on the evening of 12Jan2021. He could not get up to go to the bathroom. He had a couple of episodes of throwing up. He confirmed the throwing up has resolved, but was unable to provide any additional details. He also added that he was feeling very cold on 13Jan2021. The headaches left him concerned. At end of the call, the patient indicated he wanted this bad feeling to go away. The events did not require any visit to the Emergency Room or Physician's office (patient stated he considered it, but he just stayed in bed). Outcome of the event throwing up was recovered, for the events body does not work anymore, very cold, and headache was not recovered, while for the other events was unknown.
hearing disability and a broken foot; hearing disability and a broken foot; she woke up at 1:30 am to her knee caps aching and pounding like no tomorrow; About 8 hours later, she experienced a sore arm; very tired; chills worse than the one she got from the 1st dose; low grade fever; her face was red and hot as well as her legs; her face was red and hot as well as her legs; Had a bad reaction to both of my shots; This is a spontaneous report from a contactable consumer, the patient. A female patient of an unknown age received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot unknown, second dose) solution for injection intramuscular on 13Apr2021 (at an unknown age) as a single dose for COVID-19 vaccination. Medical history was not reported. Concomitant medication included polyethylene glycol 3350. Historical vaccine included BNT162B2 (first dose) for COVID-19 vaccination on 21Mar2021 and experienced faint, stroke, meningitis, diarrhea, could not swallow, menstrual cramps, getting sick, extreme fatigue, felt hands to be freezing, severe headache, flu-like chills, body ache, sore throat, feeling dehydrated, sinus pain, face and eyebrows hurt, throw up viscously, not understood well, profusely sweating, ice-cold ends, painful arm, neck pain, losing her mind, sheer panic, and swollen glands under her jaw. The patient experienced hearing disability and a broken foot. On 13Apr2021, about 8 hours after vaccination, she experienced a sore arm, she was very tired, chills worse than the one she got from the 1st dose, a low grade fever which felt like her whole body was on fire, her face was red and hot as well as her legs, she woke up at 1:30 am to her knee caps aching (14Apr2021) and pounding like no tomorrow. The patient had a bad reaction to both of the shots in Apr2021. The outcome of the events was unknown.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
10 days post-vaccine, I developed hives all over my hips, chest, and back. The hives flared up several times over the next few days. I was placed on a steroid for 10 days in addition to Pepcid. This helped, but following the 10-day regimen, I continued to have both major and minor flare-ups over the next two months. After consultation with my PCP and Allergist, they believe this is a rare but known side effect of COVID-19 the mRNA vaccines. NOTE: I did not have any rash or Hives following my initial two Moderna vaccine doses, they only developed after my Moderna half dose booster.
Mucus (Persists), Throat (Persists), Cough (Persists), Ailments (face) (itchiness) , Sneezing (Persists).
Pt recvd 3rd DTP on 16AUG90 later that day high temp & grand mal seizure, first seizure, since then recurrent grand mal seizures; nonfebrile & developmental arrest; work-up negative; Dx by MD as seizure disorder secondary to DTP;
Patient states she has had some pain the last couple of days, but this morning she woke up with a raised, hot rash on the arm  a couple inches below the injection site.
Patient presented for 2nd dose PFIZER vaccine. RPH reviewed VAR form, vaccine card, and handed the PFIZER vaccine to immunizing technician for administration. After immunization, technician came back into pharmacy to inform RPH she gave patient the MODERNA vaccine instead of the PFIZER vaccine.
Received flu shot 11/07 - symptoms started 2 days later - itching under arms and ribs - went away after 7 hours - started again Thursday afternoon went away that night - again Friday PM - went away within hours.  Saturday early itching.  Had whelps not sure if due to immunizations.  Whelps all over body.  Shot of cortisone by doctor, zpak, Zyrtec.  Per doctor possible allergy to preservatives in flu shot.
This spontaneous report has been received from a practice manager referring to a patient of unknown age. Information about concomitant medications, concurrent conditions, and medical history was not provided. On 21-NOV-2017, the patient were vaccinated with improperly stored GARDASIL 9 (strength, dose number, anatomical location, route of administration were unknown; lot # N019923 and expiration date 28-APR-2019) for prophylaxis. No adverse effects were reported. The reporter reported multiple temperature excursions over the past year and a half found during an audit. The excursion temperature in 08-NOV-2017, 16-NOV-2017 was 47 degree Celsius for max 15 hours. Data logger was not involved. Sender's Comments: US-009507513-1809USA003709; US-009507513-1810USA001951; US-009507513-1810USA001953; US-009507513-1810USA001954; US-009507513-1810USA001955; US-009507513-1810USA001956; US-009507513-1810USA001957; US-009507513-1810USA001958; US-009507513-1810USA001959.
Redness and swelling and warmth of the injection site started about 1 and 1/2 days after the injection.  It has continued to be sore since then.  She has taken acetaminophen, diphenhydramine and iced the site.
This is a spontaneous report from a contactable pharmacist. This pharmacist mentioned that an elderly female patient (over 65 years) of unknown ethnicity received on unspecified date the first single dose of PREVNAR13 in the arm. The patient had never received a pneumococcal vaccine. On unknown date, the patient experienced fever of 100-101 F, headache, rash in the arm at the injection site which continued to spread, fatigue, she slept 24 hour and a lot of muscle ache. She went to the emergency room and was given Prednisone for the rash and she is doing fine. The pharmacist also asked if PREVNAR 13 contained Thimerosal. The pharmacist mentioned that they have given lots of shots of  PREVNAR13 over the  years, however never had an problem like this. The pharmacist considered that the events were due to PREVNAR13. Outcome was recovered. Follow-up (02DEC2014): New information from the same contactable pharmacist includes: age group, dose number, new events (headache and fatigue), event term updated (from rash to rash at the injection site), reaction details, treatment and outcome. Follow-up (30JAN2015): Follow-up attempts completed. No further information expected.
Blood Clot and bruising on lower backside of leg, I noticed leg Pain (just uncomfortable) in the right leg at the location of clot. A time frame in relationship to the time of shot is unkown. Estimated within 24 hours. Bruising appeared morning of 04/14/21, PCP recommended in person visit. I went to urgent care, they had me drive to emergency Room at local hospital. Evaluation, blood testing and imaging concluded a blood clot in the lower right leg. Blod thinners was prescribed Eliquia 5 mg, discharged same day. It may be possible the hospital had submitted this form on my behalf.
Narrative: COVID infection following COVID vaccine series 03/08, Pfizer, dose #1 04/01, Pfizer, dose #2 10/14, Pfizer, dose #3 08/21 pt cc: cough, fatigue, loss of taste or smell, fever diarrhea, exposure; unknown 08/30 COVID swab, result: detected 08/30 SARS-COV-2 Variant Sequencing result: pending 09/07 clinically resolved
Fever of 101.4 started Wednes evening, spiked to 103.4 by the following day. Administration of ibuprofen kept temp down to 99-101 throughout Thursday and Friday. Saturday at 5 am spiked to 102.9, administration of Tylenol got it back down to 98.9. Saturday evening at 5 pm (which is current date/ time) back up to 101.7. Tylenol administered.
Temporary numbness in lower half of face. Appeared about 30-45 minutes after injection and lasted for about an hour
My period went from an average of 28-32 days between cycles and a light to medium flow to 21 days and an extremely heavy flow. I sought Dr.'s expertise. They conducted a special ultrasound and prescribed Lysteda to control the excess bleeding
Started  with a headache about 30 minutes after dose . 24 hours later ( when I awoke ) complete body pain ( especially at fibromyalgia points and where I have sarcoidosis nodules ) malaise , low grade temp , sinus and chest congestion , chills , injection site red and swollen ( 4 inches ) also nearest sarcoidosis nodule ( about 3 inches from injection site . I can still see faint pinkness of these 2 areas at this time .
pt admitted to hospital with Left MCA stroke, poor prognosis; pt is positive for COVID; transferred to in-patient hospice, comfort care; pt passed away in the hospital
5 minutes after administration stiff neck, slightly numb left cheek and left part of tongue. Tingly and itchy left side of tongue and throat. Funny taste in mouth. Took two tablets Benadryl (diphenhydramine 25 mg each) as directed by pharmacist. Drank water and rested for 30 minutes.
Everybody I know is getting the second shot and is like really sick, and a family members who got the second dose and they were really sick; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Everybody I know is getting the second shot and is like really sick, and a family members who got the second dose and they were really sick) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (Everybody I know is getting the second shot and is like really sick, and a family members who got the second dose and they were really sick). At the time of the report, ILLNESS (Everybody I know is getting the second shot and is like really sick, and a family members who got the second dose and they were really sick) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant information was provided. Treatment information was not provided.
Dr writes the following  " is a 20 y.o. female with a history of leukopenia who is here today for evaluation of lower back pain.   Patient states that she got the J&J vaccine yesterday and then over night she had onset of severe lower back pain that is localized to her back, but can occasionally be felt in her buttocks area. She first noticed body aches prior to bed. She woke around 3am to use bathroom and had terrible headache and back pain. Headache had subsided, but the back pain has persisted. The pain is located along her lower back, bilaterally. Sometimes the pain is felt in her buttocks. Pain otherwise is localized. Pain is dull, but intense. She rates the pain as a 8 or 9/10. Pain can not be alleviated. She tried a hot pack, with no relief. Laying down increases the pain, and the pain is so severe that she is unable to move. She feels afraid to move the pain is so intense. She has noticed no other symptoms. All other symptoms from the shot have subsided. Patient also became nauseated while in the exam room. Patient had negative pregnancy test yesterday. "
Information has been received through the Merck pregnancy registry from a female consumer, nurse practitioner and physician concerning female with history of caesarian delivery and abnormal past papanicolaou test and none known drug reactions / allergies, who on 22-Feb-2008 (also reported as 22-June-2008 was vaccinated intramuscularly, into left deltoid, with her 0.5ml first dose of GARDASIL (lot # 655327/128U) and found out she was pregnant (LMP) 26-Jan-2008, (also reported as 28-June-2008) . On 29-Feb-2008, the patient took pregnancy test that tested positive. The urine test for pregnancy was confirmed during the physician's office visit on 03-Mar-2008. Unspecified medical attention was sought during an office visit. No adverse symptoms. No further information was provided. Follow up information was received via pregnancy questionnaire from a physician. The patient had a history of early tobacco and discontinued with pregnancy. She had one previous pregnancy which was full term delivery and the infant complication was macrosomia. There was no other significant past medical history and concurrent medical conditions. During this pregnancy she took MACROBID 100mg bid and Phenazopyridine  hydrochloride 200mg tid to treat urinary tract infection and pseudo ephedrine HCL 300mg prn tid to treat cold / congestion. Concomitant medication included multivitamins. Diagnostic test during the pregnancy included : cystic fibrosis on 16-APR-2008 was negative, serum alpha-fetoprotein test on 16-May-2008 was negative, ultrasound on 12-Jun-2008 CWO normal anatomy, and glucose tolerance test on 16-Sep-2008 was 1/4 elevated. On 23-Oct-2008, she delivery a normal health male baby weighting 3129 grams, length 48cm, and Apgar score was 9/9 at 39 weeks from her LMP. Additional information is not expected.
Patient was administered a Pfizer Covid-19 vaccine that was exposed to a temperature excursion. (Vaccine was between 8-14.5 degrees C for 7hrs and 48 minutes). Pfizer was contacted and advised the clinic to consider the dose as invalid and to revaccinate. Patient was revaccinated 03/19/21 and has since received dose 2 on 04/09/21.
Within 15 minutes developed brain fog.  2 hours after vaccine developed fever, tinnitus, dizziness, lightheadedness,  and nausea.. To date I still have constant tinnitus and occasional brain fog and dizziness.
Pt recvd 2nd dose of Engerix-B on 23JAN92 & 30JAN92 became ill w/flu like sx; 6FEB92 visited MD for tx of fatigue, fever, loss of appetite, yellowing of eyes & rash; 8FEB92 still has jaundice, joint pain, elevated liver enzymes; tx meds;
This spontaneous report as received from a medical assistant (also reported as a healthcare worker) who administered vaccines refers to a patient of unknown age. The patient was vaccinated with the first two doses of GARDASIL (lot # and route unknown) on 11-NOV-2010 and 29-DEC-2011 respectively. No other co-suspects were reported. No concomitant medications were reported. No adverse effect reported. It was unknown that if the patient had sought medical attention. Additional information has been requested.
typical site reaction at the time of injection/The spot was raised and turned bright red; typical site reaction at the time of injection/The spot was raised and turned bright red; typical site reaction at the time of injection/my arm was sore; I felt lethargic; hot to the touch; This is a spontaneous report from a contactable other healthcare professional (patient). A 41-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number: EK9231) intramuscular on 08Jan2021 10:30 AM at single dose on the left arm for COVID-19 immunization. Patient is not pregnant. Medical history included unknown allergies(reported as "Known allergies: yes"). There were no other medical history. No COVID prior vaccination. Concomitant medications (Other medications in two weeks) included ibuprofen (ADVIL [IBUPROFEN]), fexofenadine hydrochloride (ALLEGRA 24 HOUR), diphenhydramine hydrochloride (BENADRYL) and montelukast sodium (SINGULAIR). No other vaccine in four weeks. Facility type vaccine is Hospital. The patient had a typical site reaction at the time of injection on 16Jan2021 09:00 AM. The spot was raised and turned bright red, and her arm was sore. The patient felt lethargic. After a few days those symptoms went away. The spot on her arm disappeared. Eight days later, the spot on her arm reappeared. It was bigger, bright red, and hot to the touch. Patient's arm felt sore again and she had lethargy again. A doctor confirmed it was not cellulitis. No treatment was given for the events. The events resulted in Doctor or other healthcare professional office/clinic visit. Patient was not tested for COVID-19 since the vaccination. Outcome of the events was recovering (as reported).
This spontaneous report as received from a licensed practical nurse refers to an unspecified number of patients of unknown age and gender. There were no concomitant medications, concurrent conditions and medical history reported. An unspecified number of doses of improperly stored ZOSTAVAX lot# reported as L02108, exp. 10-SEP-2016 and lot# reported as L021612, exp. 10-SEP-2016 (route of administration and dose were not reported) were administered to an unspecified number of unspecified patients by an unspecified physician on unspecified dates. There was no adverse events reported. This is one of several reports received from the same reporter. Additional information is not expected as the reporter did not wish further contact.
Patient developed a rash on the arm where the injection occurred.  The rash wasn't directly around the injection site, but on the front portion of the biceps muscle.  The patient's wife noticed the rash two days after the vaccine.  The rash wasn't blistered and it didn't itch or hurt the patient.
Migraine,  vomiting, intense injection arm pain ( unable to lift arm),  joint pain,  diarrhea
Patient was to get Pfizer bivalent vaccine the Medical Assistant accidently gave Pfizer monovalent vaccine.
Initially Fever, Fatigue, Joint Pain.  2 days later pain in right abdomen, diagnosed with Appendicitis and had emergency appendectomy performed.
Information has been received regarding a case in litigation, from a lawyer, concerning a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On an unspecified date in 2015, the patient was vaccinated with ZOSTAVAX, due to health care professional recommendation, for permanent prevention and protection against shingles and zoster-related injuries (strength, anatomical location, dose, route of administration, lot # and expiration date were not provided). In 2016, the patient was treated by a physician for shingles, as the patient was diagnosed with shingles or other related injuries after and despite being inoculated with the ZOSTAVAX vaccine, and suffered serious physical, emotional, and economic damages as a result of the patient's injuries. As a direct and proximate result of the ZOSTAVAX vaccine, the patient had and would continue suffer ongoing injuries, included but not limited to: mental and physical pain and suffering, extensive medical care and treatment for these injuries; significant medical an related expenses as a result of these injuries, included but not limited to medical losses and cost include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions. At the time of report, the patient was not recovered from emotional distress, injury and pain. The outcome of vaccination failure, quality of life decreased, herpes zoster and the pre-existing unspecified conditions aggravated was unknown. The reporter considered the events to be disabling, life-threatening and medically significant.
Injected very high on the shoulder, missing the muscle. Large Lump and swelling at the injection site, worsening bruising over the following week, worsening pain and limited range in motion in the shoulder over the month following the vaccination.
Pt reported to school after vaccine administration. After lunch pt reported to school RN with extreme itching. No other symptoms reported at this time. Parent picked child from school and brought to PMD>
Syncopal event; Nausea; Vomiting; This is a spontaneous report from a contactable nurse.  A 29-year-old female received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number:EL1284), via an unspecified route of administration on the right arm on 08Jan2021 12:15 at single dose for COVID-19 immunisation. The patient medical history was not reported.  Concomitant medication included influenza vaccine (INFLUENZA VACCINE) on 13Dec2020. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EH9899) on 18Dec2021 12:15. The patient experienced syncopal event, nausea and vomiting on 09Jan2021 05:00. The patient received no treatment. The outcome of the events was recovering.   No follow-up attempts are possible. No further information is expected.; Sender's Comments: Based on the compatible time association, the event syncope is possibly related to suspect drug BNT162B2 administration. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
11 days after sub Q injection, developed redness, swelling, tenderness 5 x 3 cm at site low grade fever
5-7 days after her vaccine, pt woke up with tingling to the L arm  and L side of face/cheek;  Has since had a few episodes of tingling to the L cheek w/o weakness, speech change, vision change. Pt's vaccine card does not have the lot # written on it.
This pt received MMR 12/16/1998. Subsequently, the pt experienced an urticarial type rash with vigorous exercise. Following cool down from the exercise, the rash dissipates.  The pt sought unspecified medical treatment. Follow-up indicated that the pt experiences an exercise and heat induced hive-like rash. The pt was ultimately diagnosed with cholinergic urticaria. No further information is available.